The Recall Desk
HighFDA (Devices)·Z-0528-2022·Announced 2022-02-02

MAGEC 1 System Recalled for Post-Implantation Component Fractures

The MAGEC 1 System implantable medical device is being recalled due to documented post-implantation fractures of an internal metallic component. The recall affects approximately 3,056 units manufactured before March 26, 2015 and distributed worldwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II medical device recall involving a documented structural failure (post-implantation metallic component fractures) in an implantable device. Per the severity rubric, a risk-of-harm product where injury has not yet been explicitly reported in the source text scores at a maximum of 3 (High).

Plain-English summary

The FDA has issued a Safety Alert regarding the MAGEC 1 System, an implantable medical device manufactured by NuVasive Specialized Orthopedics, Inc. All units manufactured prior to March 26, 2015 are subject to this recall, affecting approximately 3,056 devices distributed worldwide.

The alert concerns post-implantation fractures of an internal metallic component within the device. This structural failure occurs after implantation and represents a potential safety risk.

Surgeons and other healthcare providers have been notified via this Safety Alert. Patients with implanted MAGEC 1 Systems manufactured before March 26, 2015 should contact their healthcare provider to discuss their device and any necessary follow-up.

The recalled product

Product
MAGEC 1 System
Manufacturer
NuVasive Specialized Orthopedics, Inc.
Hazard
  • implant-fracture
  • structural-failure

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • All MAGEC Systems (Serial/Lot Numbers) manufactured prior to March 26
  • 2015.

Distribution

Distribution scope not specified by the agency.